The rising interest in GLP-1 drugs for metabolic conditions has led to a discussion about delivery routes : transdermal systems versus pills . Traditionally , GLP-1 therapies were exclusively available https://gerardcvfr131063.howeweb.com/41587891/glp-1-skin-applications-vs-oral-medications-what-best-for-the-patient